Treatment of Systemic Inflammation with Itolizumab: A Single Center Experience. acmcr [Internet]. 2022 May 20 [cited 2026 Nov. 12];6(3):442-51. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22626